IRIS Accounts Production v24.3.0.553 06943878 Board of Directors 1.7.23 31.3.24 31.3.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 10007 55405 92000 55769 81993 364 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh069438782023-06-30069438782024-03-31069438782023-07-012024-03-31069438782022-06-30069438782022-07-012023-06-30069438782023-06-3006943878ns15:EnglandWales2023-07-012024-03-3106943878ns14:PoundSterling2023-07-012024-03-3106943878ns10:Director12023-07-012024-03-3106943878ns10:PrivateLimitedCompanyLtd2023-07-012024-03-3106943878ns10:SmallEntities2023-07-012024-03-3106943878ns10:AuditExempt-NoAccountantsReport2023-07-012024-03-3106943878ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-03-3106943878ns10:SmallCompaniesRegimeForAccounts2023-07-012024-03-3106943878ns10:FullAccounts2023-07-012024-03-3106943878ns10:OrdinaryShareClass12023-07-012024-03-3106943878ns10:OrdinaryShareClass22023-07-012024-03-310694387842ns10:Director22022-06-300694387842ns10:Director22023-07-012024-03-310694387842ns10:Director22022-07-012023-06-300694387842ns10:Director22024-03-3106943878ns5:CurrentFinancialInstruments2024-03-3106943878ns5:CurrentFinancialInstruments2023-06-3006943878ns5:ShareCapital2024-03-3106943878ns5:ShareCapital2023-06-3006943878ns5:RetainedEarningsAccumulatedLosses2024-03-3106943878ns5:RetainedEarningsAccumulatedLosses2023-06-3006943878ns10:RegisteredOffice2023-07-012024-03-3106943878ns5:PlantMachinery2023-06-3006943878ns5:FurnitureFittings2023-06-3006943878ns5:PlantMachinery2023-07-012024-03-3106943878ns5:FurnitureFittings2023-07-012024-03-3106943878ns5:PlantMachinery2024-03-3106943878ns5:FurnitureFittings2024-03-3106943878ns5:PlantMachinery2023-06-3006943878ns5:FurnitureFittings2023-06-3006943878ns10:OrdinaryShareClass12024-03-3106943878ns10:OrdinaryShareClass22024-03-3106943878ns10:Director22023-07-012024-03-31069438781ns10:Director12023-06-30069438781ns10:Director12022-06-30069438781ns10:Director12023-07-012024-03-31069438781ns10:Director12022-07-012023-06-30069438781ns10:Director12024-03-31069438781ns10:Director12023-06-30
REGISTERED NUMBER: 06943878 (England and Wales)















Unaudited Financial Statements

for the Period 1st July 2023 to 31st March 2024

for

MRTD Somnolence Ltd

MRTD Somnolence Ltd (Registered number: 06943878)






Contents of the Financial Statements
for the Period 1st July 2023 to 31st March 2024




Page

Balance Sheet 1

Notes to the Financial Statements 2


MRTD Somnolence Ltd (Registered number: 06943878)

Balance Sheet
31st March 2024

31.3.24 30.6.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,483 2,083

CURRENT ASSETS
Debtors 5 11,390 8,445
Cash at bank 27,834 16,495
39,224 24,940
CREDITORS
Amounts falling due within one year 6 20,821 19,069
NET CURRENT ASSETS 18,403 5,871
TOTAL ASSETS LESS CURRENT
LIABILITIES

19,886

7,954

PROVISIONS FOR LIABILITIES 282 396
NET ASSETS 19,604 7,558

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 19,504 7,458
SHAREHOLDERS' FUNDS 19,604 7,558

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31st March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31st March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17th November 2024 and were signed on its behalf by:





Dr M I Berry - Director


MRTD Somnolence Ltd (Registered number: 06943878)

Notes to the Financial Statements
for the Period 1st July 2023 to 31st March 2024

1. COMPANY INFORMATION

MRTD Somnolence Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 06943878

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following basis:

Fixtures and Fittings - 25% on cost

Plant and Machinery - 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


MRTD Somnolence Ltd (Registered number: 06943878)

Notes to the Financial Statements - continued
for the Period 1st July 2023 to 31st March 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and
machinery fittings Totals
£    £    £   
COST
At 1st July 2023 2,398 2,360 4,758
Disposals - (2,360 ) (2,360 )
At 31st March 2024 2,398 - 2,398
DEPRECIATION
At 1st July 2023 315 2,360 2,675
Charge for period 600 - 600
Eliminated on disposal - (2,360 ) (2,360 )
At 31st March 2024 915 - 915
NET BOOK VALUE
At 31st March 2024 1,483 - 1,483
At 30th June 2023 2,083 - 2,083

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 30.6.23
£    £   
Trade debtors 11,390 8,445

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 30.6.23
£    £   
Tax 20,457 19,069
Directors' current accounts 364 -
20,821 19,069

MRTD Somnolence Ltd (Registered number: 06943878)

Notes to the Financial Statements - continued
for the Period 1st July 2023 to 31st March 2024

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.24 30.6.23
value: £    £   
60 Ordinary A £1 60 60
40 Ordinary B £1 40 40
100 100

The A Shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The B Shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The A and B Shares rank pari passu in respect of dividend and capital distribution rights.

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the period ended 31st March 2024 and the year ended 30th June 2023:

31.3.24 30.6.23
£    £   
Dr M I Berry and Mrs R A G Berry
Balance outstanding at start of period - (10,007 )
Amounts advanced 55,405 92,000
Amounts repaid (55,769 ) (81,993 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of period (364 ) -

The loan is repayable on demand and no interest was charged during the year.

9. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Dr Berry by virtue of holding 100% of the voting share capital..

10. CHANGE IN YEAR END DATE

The company has changed its accounting year-end date from June 30th to March 31st. This change is effective for the financial year ending March 31, 2024. The decision to change the year-end date was made to better align with the company’s tax reporting cycles.

As a result of this change, the financial statements for the period ending March 31, 2024, will include results for the nine-month period from July 1, 2023, to March 31, 2024. Comparative figures for the prior year will be presented for the twelve months ended June 30, 2023. This transition will not affect the company’s overall financial position but will result in a shift in reporting periods.